Company Profile

Natglycan Inc (AKA: Natglycan LLC)
Profile last edited on: 3/2/2021      CAGE: 7KV47      UEI: NMMMHXNPL8U5

Business Identifier: Novel approach to released N-glycans, O-glycans and GSLglycans directly from natural sources using inexpensive, simple chemical methods
Year Founded
2016
First Award
2017
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2342 Oakshire Court
Decatur, GA 30033
   (678) 481-8413
   info@natglycan.com
   www.natglycan.com
Location: Single
Congr. District: 04
County: DeKalb

Public Profile

Co-founded by two Emory university professors- in Atlanta, GA - NatGlycan, LLC is a biotech corporation focused on large-scale natural glycans. Principals of the firm have developed proprietary glycan extraction techniques that enable llarge scale preparation of natural glycans. The firm's proprietary process is based on a controlled oxidation using sodium hypochlorite (household bleach). Principals describe most natural glycans occuring as glycoconjugates - glycans are attached to other biomolecules such as proteins or lipids. Due to the high oxidation state of glycans, they are much more resistant to oxidative degradation than proteins and lipids including their linkages with glycans. As a result N-, O-glycans from glycoproteins and glycans from glycosphingolipids are quickly released by bleach with different reducing end structures and can be easily derivatized with fluorescent tags. Released N-, O- and GSL-glycans possess different reducing end structures and can be further derivatized for HPLC seperation

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $314,971
Project Title: A Human Salivary Glycome Discovery Platform for Interrogating Glycan Function in Oral Innate Immunity
2021 2 NIH $2,170,937
Project Title: Natural Glycans for Functional Glycomics
2020 2 NIH $289,301
Project Title: A Natural Glycan Array of the Human Milk Glycome
2017 1 NIH $285,524
Project Title: Large Scale Preparation of Natural Glycans

Key People / Management

  David Fletcher Smith -- CEO

  Janice Kimpel -- Chief Business Officer

  Xuezheng Song

Company News

There are no news available.